Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1017 Bki-1770
Novel Bumped-Kinase Inhibitor (BKI) for Cryptosporidiosis Therapy
More description
DCC1016 Bki-1708
Novel Bumped-Kinase Inhibitor (BKI) for Cryptosporidiosis Therapy
More description
DCC1015 Bjp-06-005-3
Novel potent and selective covalent Pin1 inhibitor
More description
DCC1014 Bjff078
Potent inhibitor of recombinant human and mouse Transglutaminase enzyme activity, mainly TG2 and the close related enzyme TG1
More description
DCC1013 Bix-02188me
Potent and selective dual inhibitor of MEK5 and ERK5
More description
DCC1012 Bit-l15
Novel potent antagonist of RORγt function, displaying an increased selectivity for RORγt over RORα and PPARγ compared to the purely orthosteric and allosteric non-PEG-linked parent compounds
More description
DCC1011 Bitc-sg
Inactivator of GSTP1>GST P1-1 through the covalent modification of two Cys47 residues per dimer and one Cys101
More description
DCC1010 Bisthianostat
Novel Orally Efficacious Pan-HDAC Inhibitor
More description
DCC1009 Bis-salicyl Fumarate
Potent activator of the Neh2-luc reporter
More description
DCC1008 Bisoctrizole
UV stabilizer
More description
DCC1007 bis-n-norgliovictin
Novel inhibitor of LPS-induced inflammation in macrophages, improving survival in sepsis
More description
DCC1006 Bisleuconothine A
Novel and selective Wnt signaling inhibitor
More description
DCC1005 Bisindole-pbd
Novel inhibitor of angiogenesis by regulating STAT3 and VEGF in breast cancer cells
More description
DCC1004 Bisdionin F
Selective hAMCase Inhibitor
More description
DCC1003 Bis-cyclosal-d4tmp
Novel anti-HIV active dimeric prodrug of 2‘,3‘-dideoxy-2‘,3‘-didehydrothymidine monophosphate (d4TMP)
More description
DCC1002 Bisaramil
Class I antiarrhythmic agent with chronotropic, inotropic, dromotropic and coronary vasodilator effects, potently blocking sodium channel
More description
DCC1001 Bis-5-methyl-cyclosal-d4tmp
Novel anti-HIV active dimeric prodrug of 2‘,3‘-dideoxy-2‘,3‘-didehydrothymidine monophosphate (d4TMP)
More description
DCC1000 Bis-2-ai Adjuvant-2
Novel adjuvant to repurpose azithromycin for use against Pseudomonas aeruginosa, exhibiting a 1024-fold reduction in the minimum inhibitory concentration of azithromycin in vitro and displays activity in a Galleria mellonella model of infection
More description
DCC0999 Biphalin
Potent peptide opioid receptor agonist, alleviating LPS-Induced activation in rat primary microglial cultures in opioid receptor-dependent and receptor-independent manners
More description
DCC0998 Biph(2,3',4,5',6)p5
Potent inhibitor of SHIP-2 catalytic activity; Novel inositol polyphosphate surrogate modulating Ca responses in rat hepatocytes
More description
DCC0997 Bipbipu
Novel heparanase inhibitor
More description
DCC0996 Bio-0554019
Novel selective RORgamma inhibitor, selectively inhibiting Th17 differentiation and RORgamma signature gene expression
More description
DCC0995 Bin-01-07-07
Novel USP28 inhibitor
More description
DCC0994 bim5078
Potent HNF4α antagonist
More description
DCC0993 Biliatresone
Natural Biliary Toxin, causing extrahepatic biliary atresia
More description
DCC0992 Biii-890cl
Novel potent blocker of Nav1.2 sodium channels, protecting of brain tissue from ischemia
More description
DCC0991 Biii-277cl
Novel potent blocker of the NMDA receptor ion channel
More description
DCC0990 Biib068 Hemi-adipate
Novel, Selective, Potent, Reversible Bruton's Tyrosine Kinase (BTK) Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases
More description
DCC0989 Biib-057
Selective Syk inhibitor
More description
DCC0988 Biib028
Novel selective heat shock protein 90 inhibitor, prodrug of CF2772
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X